JAK2 inhibitor treatment of anemia in myelofibrosis

被引：2
作者：
Tefferi, Ayalew [1 ,3 ]
Vannucchi, Alessandro M. [2 ]
机构：
[1] Mayo Clin, Dept Med, Div Hematol, Rochester, MN USA
[2] Univ Florence, Ctr Res & Innovat Myeloproliferat Neoplasms, CRIMM, AOU Careggi, Florence, Italy
[3] Mayo Clin, Dept Med, Div Hematol, 200 First St SW, Rochester, MN 55905 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 07期
关键词：
AVAILABLE THERAPY; MOMELOTINIB; RUXOLITINIB; TRIAL; FEDRATINIB; SURVIVAL; EFFICACY; HEPCIDIN; SAFETY;
D O I：
10.1002/ajh.26934
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：995 / 997
页数：3
相关论文
共 30 条
[1]   Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents [J].
Asshoff, Malte ;
Petzer, Verena ;
Warr, Matthew R. ;
Haschka, David ;
Tymoszuk, Piotr ;
Demetz, Egon ;
Seifert, Markus ;
Posch, Wilfried ;
Nairz, Manfred ;
Maciejewski, Pat ;
Fowles, Peter ;
Burns, Christopher J. ;
Smith, Gregg ;
Wagner, Kay-Uwe ;
Weiss, Guenter ;
Whitney, J. Andrew ;
Theurl, Igor .
BLOOD, 2017, 129 (13) :1823-1830
[2]   Determinants of survival and retrospective comparisons of 183 clinical trial patients with myelofibrosis treated with momelotinib, ruxolitinib, fedratinib or BMS-911543 JAK2 inhibitor [J].
Gangat, Naseema ;
Begna, Kebede H. ;
Al-Kali, Aref ;
Hogan, William ;
Litzow, Mark ;
Pardanani, Animesh ;
Tefferi, Ayalew .
BLOOD CANCER JOURNAL, 2023, 13 (01)
[3]   Predictors of anemia response to momelotinib therapy in myelofibrosis and impact on survival [J].
Gangat, Naseema ;
Begna, Kebede H. ;
Al-Kali, Aref ;
Hogan, William ;
Litzow, Mark ;
Pardanani, Animesh ;
Tefferi, Ayalew .
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (02) :282-289
[4]   Limited activity of luspatercept in myelofibrosis and myeloid neoplasms other than myelodysplastic syndromes with ring sideroblasts [J].
Gangat, Naseema ;
Chetram, Deandra ;
McCullough, Kristen ;
Al-Kali, Aref ;
Begna, Kebede ;
Hogan, William ;
Litzow, Mark ;
Foran, James ;
Badar, Talha ;
Palmer, Jeanne ;
Patnaik, Mrinal ;
Pardanani, Animesh ;
Tefferi, Ayalew .
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (12) :E474-E477
[5]   MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis [J].
Guglielmelli, Paola ;
Lasho, Terra L. ;
Rotunno, Giada ;
Mudireddy, Mythri ;
Mannarelli, Carmela ;
Nicolosi, Maura ;
Pacilli, Annalisa ;
Pardanani, Animesh ;
Rumi, Elisa ;
Rosti, Vittorio ;
Hanson, Curtis A. ;
Mannelli, Francesco ;
Ketterling, Rhett P. ;
Gangat, Naseema ;
Rambaldi, Alessandro ;
Passamonti, Francesco ;
Barosi, Giovanni ;
Barbui, Tiziano ;
Cazzola, Mario ;
Vannucchi, Alessandro M. ;
Tefferi, Ayalew .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04) :310-+
[6]   A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis [J].
Gupta, Vikas ;
Mesa, Ruben A. ;
Deininger, Michael W. N. ;
Rivera, Candido E. ;
Sirhan, Shireen ;
Brachmann, Carrie Baker ;
Collins, Helen ;
Kawashima, Jun ;
Xin, Yan ;
Verstovsek, Srdan .
HAEMATOLOGICA, 2017, 102 (01) :94-102
[7]   JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis [J].
Harrison, Claire ;
Kiladjian, Jean-Jacques ;
Al-Ali, Haifa Kathrin ;
Gisslinger, Heinz ;
Waltzman, Roger ;
Stalbovskaya, Viktoriya ;
McQuitty, Mari ;
Hunter, Deborah S. ;
Levy, Richard ;
Knoops, Laurent ;
Cervantes, Francisco ;
Vannucchi, Alessandro M. ;
Barbui, Tiziano ;
Barosi, Giovanni .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (09) :787-798
[8]   Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry [J].
Hernandez-Boluda, Juan-Carlos ;
Pereira, Arturo ;
Kroeger, Nicolaus ;
Cornelissen, Jan J. ;
Finke, Juergen ;
Beelen, Dietrich ;
de Witte, Moniek ;
Wilson, Keith ;
Platzbecker, Uwe ;
Sengeloev, Henrik ;
Blaise, Didier ;
Einsele, Hermann ;
Sockel, Katja ;
Krueger, William ;
Lenhoff, Stig ;
Salaroli, Adriano ;
Martin, Hans ;
Garcia-Gutierrez, Valentin ;
Pavone, Vicenzo ;
Alvarez-Larran, Alberto ;
Raya, Jose-Maria ;
Zinger, Nienke ;
Gras, Luuk ;
Hayden, Patrick ;
Czerw, Tomasz ;
P. McLornan, Donal ;
Yakoub-Agha, Ibrahim .
AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (10) :1186-1194
[9]   Comprehensive profiling of clinical JAK inhibitors in myeloproliferative neoplasms [J].
Kong, Tim ;
Yu, LaYow ;
Laranjeira, Angelo B. A. ;
Fisher, Daniel A. C. ;
He, Fan ;
Cox, Maggie J. J. ;
Oh, Stephen T. T. .
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (07) :1029-1042
[10]   Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis [J].
McLornan, D. ;
Eikema, D. J. ;
Czerw, T. ;
Kroger, N. ;
Koster, L. ;
Reinhardt, Hans Christian ;
Angelucci, E. ;
Robin, M. ;
Bornhauser, M. ;
Passweg, J. ;
Clark, A. ;
Vydra, J. ;
Blau, I. E. ;
Niittyvuopio, R. ;
Platzbecker, U. ;
Cornelissen, J. J. ;
Chevallier, P. ;
Srour, M. ;
Stamatovic, D. ;
Martinez-Lopez, J. ;
de Wreede, L. ;
Hayden, P. ;
Hernandez-Boluda, J. C. ;
Yakoub-Agha, I. .
BONE MARROW TRANSPLANTATION, 2021, 56 (09) :2160-2172
123